Some other findings indicated that the downregulation of Socs3 in the microglia/macrophages could lead to a marked bias toward the M2 phenotype and ameliorate the inflammation, which could promote neuroprotective effects after stroke (51). The gene discussed is SOCS3; the disease is stroke disorder.